| # | Drug | Count |
|---|---|---|
| 0 | FOSAPREPITANT DIMEGLUMINE | 26 |
| 1 | DEXAMETHASONE | 12 |
| 2 | DEXAMETHASONE 1.5 MG | 12 |
| 3 | EPIRUBICIN HYDROCHLORIDE | 12 |
| 4 | ONDANSETRON | 12 |
| 5 | ONDANSETRON HYDROCHLORIDE | 12 |
| 6 | ONDANSETRON TABLETS | 12 |
| 7 | CYCLOPHOSPHAMIDE | 11 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEMIN | 2 | 0.0034 |
| 1 | ETOMIDATE INJECTION | 5 | 0.0023 |
| 2 | ETOMIDATE | 5 | 0.0022 |
| 3 | FOSAPREPITANT DIMEGLUMINE | 26 | 0.0019 |
| 4 | EPIRUBICIN HYDROCHLORIDE | 12 | 0.0018 |
| 5 | SOYBEAN OIL | 1 | 0.0015 |
| 6 | TEDIZOLID PHOSPHATE | 1 | 0.0012 |
| 7 | IRON SUCROSE | 9 | 0.0009 |
| 8 | RILONACEPT | 1 | 0.0009 |
| 9 | MEPROBAMATE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 19 |
| 1 | Alkylating Drug [EPC] | 14 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 14 |
| 4 | Platinum-based Drug [EPC] | 13 |
| 5 | Parenteral Iron Replacement [EPC] | 10 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 8 |
| 7 | Osmotic Laxative [EPC] | 8 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 7 |
| 9 | Benzodiazepine [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parenteral Iron Replacement [EPC] | 10 | 0.0007 |
| 1 | Interferon gamma [EPC] | 1 | 0.0007 |
| 2 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 5 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 6 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 7 | Radiographic Contrast Agent [EPC] | 4 | 0.0002 |
| 8 | Phenothiazine [EPC] | 4 | 0.0001 |
| 9 | General Anesthetic [EPC] | 5 | 0.0001 |